Patents by Inventor Scott Duncan

Scott Duncan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10117846
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: November 6, 2018
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Patent number: 10080733
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: September 25, 2018
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Patent number: 10005790
    Abstract: The present invention relates to compounds of formula I and a process for the synthesis: The invention further relates to a process for the synthesis of 3-carboxamide substituted morphinans where a 3-cyano substituted 6-oxo substituted morphinan is reacted with a 1,3-diol.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: June 26, 2018
    Assignee: Alkermes Pharma Ireland Limited
    Inventor: Scott Duncan
  • Publication number: 20180064673
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 14, 2017
    Publication date: March 8, 2018
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Publication number: 20180042881
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 12, 2017
    Publication date: February 15, 2018
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Publication number: 20180044378
    Abstract: The present technology provides methods of generating the peptides, and pharmaceutically acceptable salts of the peptides and intermediates thereof. In some embodiments, the peptide is D-Arg-2?6?-Dmt-Lys-Phe-NH2.
    Type: Application
    Filed: March 7, 2016
    Publication date: February 15, 2018
    Inventors: Scott DUNCAN, D. Travis WILSON
  • Publication number: 20180030063
    Abstract: The present invention provides compounds of formula (I), wherein: R1 is unsubstituted C1-C6 alkyl; La is substituted or unsubstituted C1-C6 alkyl linker, substituted or unsubstituted C3-C10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R2 and R3 are each, independently, H, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C6-C10 aryl; or alternatively, R2 and R3, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S.
    Type: Application
    Filed: August 22, 2017
    Publication date: February 1, 2018
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Patent number: 9775823
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: October 3, 2017
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Publication number: 20170095439
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 17, 2016
    Publication date: April 6, 2017
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Patent number: 9505776
    Abstract: The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 29, 2016
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Publication number: 20160137660
    Abstract: The present invention provides compounds of formula (I), wherein: R1 is unsubstituted C1-C6 alkyl; La is substituted or unsubstituted C1-C6 alkyl linker, substituted or unsubstituted C3-C10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R2 and R3 are each, independently, H, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C6-C10 aryl; or alternatively, R2 and R3, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 19, 2016
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Publication number: 20160090658
    Abstract: Systems, methods, and other embodiments associated with thermal electrolytic production. According to one embodiment, a system includes a tower having an active reflux evaporator and a condenser system. The active reflux evaporator having a distributor pump assembly and an absorber. The distributor pump assembly pumps a heat pipe liquid metal to a distributor. The absorber receives the liquid metal from the distributor. The absorber facilitates evaporation of the liquid metal to form an evaporated metal. The condenser system includes a thermal load and a liquid pump assembly. The thermal load condenses the evaporated metal back to the liquid metal. The liquid pump assembly actively pumps the liquid metal to the distributor pump assembly.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 31, 2016
    Applicant: VALPARAISO UNIVERSITY
    Inventors: Richard Diver, Gregory Scott Duncan, Michal Korenko, Carol Larson, Shahin Nudehi, Robert Palumbo, Jonathan Schoer, Luke Venstrom
  • Patent number: 9162401
    Abstract: A preferred process for degassing a mold piece includes inserting the mold piece into an internal volume within a canister, sealing the internal volume, drawing a vacuum in the internal volume, and introducing into the internal volume a gaseous fluid suitable for degassing the mold piece.
    Type: Grant
    Filed: October 20, 2009
    Date of Patent: October 20, 2015
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Donnie J. Duis, Stephen R. Beaton, David C. Byram, Gregory Scott Duncan
  • Publication number: 20150284333
    Abstract: The invention relates to a process for the synthesis of quaternized compounds of formula:
    Type: Application
    Filed: April 9, 2015
    Publication date: October 8, 2015
    Inventor: Scott Duncan
  • Publication number: 20150283677
    Abstract: A grinding system that can include a polisher.
    Type: Application
    Filed: November 3, 2014
    Publication date: October 8, 2015
    Inventors: Rodney Karppinen, Scott Duncan
  • Publication number: 20150216644
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: August 8, 2013
    Publication date: August 6, 2015
    Applicant: ATTENUX TECHNOLOGIES, INC.
    Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William Gruber, John Gillespie, JR., Sheila Caira
  • Patent number: 9090558
    Abstract: The present invention provides compounds of formula (I), wherein: R1 is unsubstituted C1-C6 alkyl; La is substituted or unsubstituted C1-C6 alkyl linker, substituted or unsubstituted C3-C10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R2 and R3 are each, independently, H, substituted or unsubstituted C1-C6 alkyl, or substituted or unsubstituted C6-C10 aryl; or alternatively, R2 and R3, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: July 28, 2015
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Tarek A. Zeidan, Scott Duncan, Christopher P. Hencken, Thomas Andrew Wynn, Carlos N. Sanrame
  • Patent number: 9029543
    Abstract: The invention relates to a process for the synthesis of quaternized compounds of formula:
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: May 12, 2015
    Assignee: Alkermes, Inc.
    Inventor: Scott Duncan
  • Patent number: 8947380
    Abstract: A method includes displaying keys of a keyboard in a keyboard area on a touch-sensitive display, at least one of the keys being associated with multiple letter characters, the keyboard area located adjacent to a first side of the touch-sensitive display, detecting a touch in a keyboard area of the touch-sensitive display, the touch being associated with a character input, detecting a gesture in a gesture input area of a touch-sensitive display, the gesture area located adjacent to a second side of the touch-sensitive display, the second side opposite to the first side; wherein the gesture is associated with a keyboard-related function at the processor and the keyboard-related function is operable on the character input or a next character input.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: February 3, 2015
    Assignee: Blackberry Limited
    Inventors: Jerome Pasquero, David Ryan Walker, Scott Duncan Inglis
  • Publication number: 20140303371
    Abstract: The present invention relates to a process for the synthesis of a compound of formula I:
    Type: Application
    Filed: March 6, 2014
    Publication date: October 9, 2014
    Applicant: Alkermes Pharma Ireland Limited
    Inventor: Scott Duncan